NIH Stimulus Grants to Consider Bioethics

Apr 13, 2009

NEW YORK (GenomeWeb News) – The 15 "challenge areas" highlighted by the National Institutes of Health in its Challenge Grants program — which will distribute $200 million in stimulus funding to a variety of biomedical research areas — include grants for studies that explore bioethical questions and for developing new information technology for use in personalized medicine.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Ways to Make the Move

A new report offers ways for small, society publishers to transition to Plan S standards, ScienceInsider says.

Fire at Russian Pathogen Lab

A gas explosion sparked a fire at a Russian laboratory that stores dangerous pathogens, the Guardian reports.

Proteins From the Past

Researchers turn to protein analysis to examine an ancient rhino sample, Smithsonian.com reports.

PNAS Studies Look at Diabetes Susceptibility, S. Aureus Subpopulations, More

In PNAS this week: C2CD4A gene involved in insulin secretion, chromosome rearrangements in recurring S. aureus infections, and more.

Featured White Papers

The 'Dark Matter' of Cancer Genomics: Revealing Undetected Structural Variants in Leukemia White Paper

Investigating the Human Immune Response with Myriad RBM’s TruCulture System and the NanoString nCounter Autoimmune Profiling Panel

Measuring DNA Concentration with Less Time and More Accuracy

Sample Normalization with RNAGEM

Oct

23

Featured Webinar

Single-Cell Methylation Profiling of Pediatric Tumors via a Unique NGS-based Approach

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.

Oct

24

Featured Webinar

Designing, Decoding & Delivering on Genetic Testing for Inherited Disease at Versiti

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

Menu